2m 2m 2m 2m 2m 2m 2m
Johnson&Johnson (JNJ)
NYSE
$267.51+$9.73 (+3.77%)
Price as of Oct 22, 2026 7:59 PM EDT- $621.2BMarket Cap
- 36.62%1-Year Change
- Drug Manufacturers - GeneralIndustry
Johnson&Johnson (JNJ)
$267.51+$9.73 (+3.77%)
JNJ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $257.78 | ||
Change | -$1.58 (-0.61%) | ||
Open | $257.50 | ||
High | $257.80 | ||
Low | $254.56 | ||
Previous Close | $259.36 | ||
Volume | 6,557,033 | ||
30-Day Average Volume | 7,415,170 | ||
1-Week Change | 1.52% | ||
1-Month Change | -4.34% | ||
1-Year Change | 36.62% | ||
3-Year Change | 83.48% | ||
5-Year Change | 81.40% | ||
Fundamentals | |||
Shares Outstanding | 2.4B | ||
Total Assets | $197.4B | ||
Market Cap | $621.2B | ||
Enterprise Value | $649.0B | ||
Period: QTR TTM FY | |||
Revenue | $25.4B | ||
Net Income | $210.0M | ||
Free Cash Flow | $6.4B | ||
EBIT | $34.0M | ||
EBITDA | $2.2B | ||
Net Working Capital | $894.0M | ||
EPS | $0.09 | ||
Enterprise Value/EBITDA | 302 | ||
Enterprise Value/Revenue | 26 | ||
P/B | 8 | ||
P/E | 2,864 | ||
PEG | -30 | ||
Price/Free Cash Flow | 98 | ||
Price/Operating Cash Flow | 80 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.08% | ||
Trailing Annual Dividend Yield | 2.05% | ||
Ex-Dividend Date | 11/24/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield